|
⚲
|
| Keyboard |
| Lanza Frank J
✚
|
|
|---|---|
| CIK # | 0001624055 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001624055] | |
| 4 | [0001624055] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lanza Frank J | |
| Harpoon Therapeutics Inc | |
| Horizon Pharmaceutical LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Harpoon Therapeutics Inc HARP
Employee Stock Option (Right to Buy) · derivative
|
2024-03-11 | Disposed to issuer | 6,499 | ||
|
Harpoon Therapeutics Inc HARP
Common Stock
|
2024-03-11 | Disposed to issuer | 18,734 | ||
|
Harpoon Therapeutics Inc HARP
Employee Stock Option (Right to Buy) · derivative
|
2024-03-11 | Disposed to issuer | 8,643 | ||
|
Harpoon Therapeutics Inc HARP
Common Stock
|
2024-01-07 | Grant | 15,000 | $0.00 | |
|
Harpoon Therapeutics Inc HARP
Common Stock
|
2023-11-26 | Grant | 2,000 | $0.00 | |
|
Harpoon Therapeutics Inc HARP
Employee Stock Option (right to buy) · derivative
|
2023-01-24 | Grant | 65,000 | $0.00 | |
|
Harpoon Therapeutics Inc HARP
Employee Stock Option (right to buy) · derivative
|
2022-11-22 | Grant | 86,438 | $0.00 |